-
High-throughput discovery of genetic determinants of circadian misalignment.
Zhang T(1), Xie P(1), Dong Y(1), Liu Z(1), Zhou F(1), Pan D(1), Huang Z(1), Zhai Q(1), Gu Y(1), Wu Q(2)(3), Tanaka N(4), Obata Y(4), Bradley A(5), Lelliott CJ(5); Sanger Institute Mouse Genetics Project, Nutter LMJ(6), McKerlie C(6), Flenniken AM(6), Champy MF(7), Sorg T(7), Herault Y(7), Angelis MH(8)(9), Durner VG(8), Mallon AM(10), Brown SDM(10), Meehan T(11), Parkinson HE(11), Smedley D(12), Lloyd KCK(13), Yan J(14), Gao X(14), Seong JK(15), Wang CL(16), Sedlacek R(9), Liu Y(17), Rozman J(8)(9)(18), Yang L(1), Xu Y(1)(3).
PLoS Genet Jan. 13, 2020
-
Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.
Lionello VM(1)(2)(3)(4), Nicot AS(1)(2)(3)(4)(5)(6), Sartori M(1)(2)(3)(4), Kretz C(1)(2)(3)(4), Kessler P(1)(2)(3)(4), Buono S(1)(2)(3)(4), Djerroud S(1)(2)(3)(4), Messaddeq N(1)(2)(3)(4), Koebel P(1)(2)(3)(4), Prokic I(1)(2)(3)(4), Herault Y(1)(2)(3)(4), Romero NB(7)(8)(9), Laporte J(10)(2)(3)(4), Cowling BS(1)(2)(3)(4).
Sci Transl Med March 20, 2019
-
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation.
Sartori M(1)(2)(3)(4), Mendes T(5)(6)(7)(8), Desai S(5)(6)(7), Lasorsa A(7)(9), Herledan A(6)(10)(11), Malmanche N(5)(6)(7), Makinen P(12), Marttinen M(12), Malki I(7)(9), Chapuis J(5)(6)(7), Flaig A(5)(6)(7), Vreulx AC(5)(6)(7), Ciancia M(1)(2)(3)(4), Amouyel P(5)(6)(7), Leroux F(6)(10)(11), Deprez B(6)(10)(11), Cantrelle FX(7)(9), Marechal D(1)(2)(3)(4), Pradier L(8), Hiltunen M(12), Landrieu I(7)(9), Kilinc D(5)(6)(7), Herault Y(13)(14)(15)(16), Laporte J(17)(18)(19)(20), Lambert JC(21)(22)(23).
Acta Neuropathol May 7, 2019
-
Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a.
Marechal D(1)(2)(3)(4), Brault V(1)(2)(3)(4), Leon A(5), Martin D(1)(2)(3)(4), Pereira PL(6), Loaec N(5), Birling MC(7), Friocourt G(5), Blondel M(5), Herault Y(1)(2)(3)(4)(7).
Hum Mol Genet May 1, 2019
-
Erratum: Author Correction: Identification of genes required for eye development by high-throughput screening of mouse knockouts.
Moore BA(1), Leonard BC(#)(2), Sebbag L(#)(1), Edwards SG(1), Cooper A(1), Imai DM(3), Straiton E(4), Santos L(4), Reilly C(3), Griffey SM(3), Bower L(5), Clary D(5), Mason J(6), Roux MJ(7)(8)(9)(10)(11), Meziane H(7)(8)(9)(10)(11), Herault Y(7)(8)(9)(10)(11); International Mouse Phenotyping Consortium, McKerlie C(12)(13), Flenniken AM(12)(14), Nutter LMJ(12)(13), Berberovic Z(12)(14), Owen C(12)(14), Newbigging S(12)(14), Adissu H(12)(14), Eskandarian M(12)(14), Hsu CW(15), Kalaga S(15), Udensi U(15), Asomugha C(15), Bohat R(16), Gallegos JJ(16), Seavitt JR(16), Heaney JD(16), Beaudet AL(16), Dickinson ME(15)(16), Justice MJ(12)(13)(16), Philip V(17), Kumar V(17), Svenson KL(17), Braun RE(17), Wells S(4), Cater H(4), Stewart M(4), Clementson-Mobbs S(4), Joynson R(4), Gao X(18), Suzuki T(19), Wakana S(19), Smedley D(20), Seong JK(21), Tocchini-Valentini G(22), Moore M(23), Fletcher C(24), Karp N(25), Ramirez-Solis R(25), White JK(17)(25), de Angelis MH(26), Wurst W(26), Thomasy SM(2)(27), Flicek P(6), Parkinson H(6), Brown SDM(4), Meehan TF(6), Nishina PM(17), Murray SA(17), Krebs MP(17), Mallon AM(4), Kent Lloyd KC(5), Murphy CJ(2)(27), Moshiri A(27).
Commun Biol March 7, 2019
-
Genetic quality assurance and genetic monitoring of laboratory mice and rats: FELASA Working Group Report.
Benavides F(1), Rulicke T(2), Prins JB(3)(4), Bussell J(5), Scavizzi F(6), Cinelli P(7), Herault Y(8)(9), Wedekind D(10).
Lab Anim Aug 20:2367721986771 2019
-
HENA, heterogeneous network-based data set for Alzheimer's disease.
Sugis E(1)(2), Dauvillier J(3), Leontjeva A(4), Adler P(1)(2), Hindie V(5), Moncion T(5), Collura V(5), Daudin R(6)(7), Loe-Mie Y(8), Herault Y(9), Lambert JC(10), Hermjakob H(11), Pupko T(12), Rain JC(5), Xenarios I(13)(14)(15)(16), Vilo J(1)(2), Simonneau M(17)(18), Peterson H(19)(20).
Sci Data Aug. 14, 2019
-
Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an alpha5-selective GABAA inverse agonist.
Duchon A(1)(2)(3)(4), Gruart A(5), Albac C(6)(7)(8)(9), Delatour B(6)(7)(8)(9), Zorrilla de San Martin J(6)(7)(8)(9), Delgado-Garcia JM(5), Herault Y(1)(2)(3)(4), Potier MC(6)(7)(8)(9).
Br J Pharmacol Oct. 25, 2019
